Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

SENgEAR: an interactive visualization platform for comparative analysis of senescence signatures and cellular communication

Created on 04 Nov 2026

Authors

Nagaraj, S., Adkins, R. S., Rindone, A. N., Das, A., Lesperance, D., Orvis, J., Krishnan, K., Cosgrove, B. D., Basisty, N., Baker, D. J., White, O. R., Mahurkar, A. A., Elisseeff, J. H., Fertig, E. J.

Abstract

Single-cell and spatial transcriptomic datasets provide tremendous potential to identify the cellular states and communication networks associated with senescence. Annotating senescent cells in these datasets is hindered by the lack of universal markers for senescent cells and their context-dependent variability. To overcome this, several groups have developed gene signatures to annotate cells with distinct senotypes. However, comparing these signatures and their biological contexts to determine the specificity of senescence signatures remains complicated by the separate data platforms for signatures and datasets. We present SENgEAR, a no-code web platform for senescent cell annotation, visualization of cell-cell communication networks, and comparison of senescence signatures across studies, tissues, species, and data modalities. SENgEAR provides a unified framework to explore contextual signature specificity, cellular communication pathways, and senotype heterogeneity. We demonstrate the use of SENgEAR for applications spanning aging, fibrosis, and wound healing and its ability to interrelate these states.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 04 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement